Neuropathies associated with lymphoma

Neuro-Oncology Practice

Volumn 2, Issue 4, 2015, Pages 167-178

  Grisold, Wolfgang ^a   Grisold, Anna ^b   Marosi, Christine ^b   Meng, Stefan ^a   Briani, Chiara ^c  

^a KAISER FRANZ JOSEF HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Intravascular lymphoma; Lymphoma; Neurolymphomatosis; Paraneoplastic; Peripheral nerves; Toxic neuropathies

Indexed keywords

BORTEZOMIB; BRENTUXIMAB VEDOTIN; CAPECITABINE; CARFILZOMIB; CD20 ANTIBODY; CYCLOPHOSPHAMIDE; CYTARABINE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; NAVELBINE; NELARABINE; THALIDOMIDE; VEDOTIN;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CYTOMEGALOVIRUS INFECTION; ELECTROPHYSIOLOGY; GUILLAIN BARRE SYNDROME; HAND FOOT SYNDROME; HUMAN; IMMUNOGLOBULIN DEPOSITION; IMMUNOSUPPRESSIVE TREATMENT; LARGE CELL LYMPHOMA; LUMBOSACRAL PLEXUS; LYMPHOMA; LYMPHOMATOSIS; MONONEUROPATHY; MOTOR NEUROPATHY; NERVE CONDUCTION VELOCITY; NEUROPATHY; NEUROTOXICITY; NONHODGKIN LYMPHOMA; PARANEOPLASTIC NEUROPATHY; PARAPROTEINEMIC NEUROPATHY; PATIENT CARE; PERIPHERAL NERVE TUMOR; POLYRADICULONEUROPATHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION INJURY;

EID: 84974586206     PISSN: 20542577     EISSN: 20542585     Source Type: Journal    
DOI: 10.1093/nop/npv025     Document Type: Article

References (137)

1. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press, 2008.
2. Huh J. Epidemiologic overview of malignant lymphoma. Korean J Hematol. 2012;47(2):92-104.
3. Globocan. International Agency for Research on Cancer. Available at http://globocan.iarc.fr/. Assessed at March 6, 2015.
4. Novelli S, Sierra J, Briones J. New therapies in non-Hodgkin lymphoma. Expert Rev Anticancer Ther. 2015;15(3):349-359.
5. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst. 2008;13(1):27-46.
6. Giometto B, Grisold W, Vitaliani R, et al. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol. 2010;67(3):330-335.
7. Briani C, Vitaliani R, Grisold W, et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology. 2011;76(8):705-710.
8. Kelly JJ, Karcher DS. Lymphoma and peripheral neuropathy:A clinical review. Muscle Nerve. 2005;31(3):301-313.
9. Dakwar E, Teja S, Alleyne CH Jr. Sciatic neurolymphomatosis. Neurology. 2004;63(9):1751.
10. Descamps MJ, Barrett L, Groves M, et al. Primary sciatic nerve lymphoma: a case report and review of the literature. J Neurol Neurosurg Psychiatry. 2006;77(9):1087-1089.
11. Gonzalvo A, McKenzie C, Harris M, Biggs M. Primary non-Hodgkin's lymphoma of the radial nerve: case report. Neurosurgery. 2010; 67(3):872-873.
12. Misdraji J, Ino Y, Louis DN, Rosenberg AE, Chiocca EA, Harris NL. Primary lymphoma of peripheral nerve: report of four cases. Am J Surg Pathol. 2000;24(9):1257-1265.
13. Moore KR, Blumenthal DT, Smith AG, Ward JH. Neurolymphomatosis of the lumbar plexus: high resolution MR neurography findings. Neurology. 2001;57(4):740-742.
14. Pietrangeli A, Milella M, De Marco S, et al. Brachial plexus neuropathy as unusual onset of diffuse neurolymphomatosis. Neurol Sci. 2000;21(4):241-245.
15. Pillay PK, Hardy RW Jr, Wilbourn AJ, Tubbs RR, Lederman RJ. Solitary primary lymphoma of the sciatic nerve: case report. Neurosurgery. 1988;23(3):370-371.
16. Quinones-Hinojosa A, Friedlander RM, Boyer PJ, Batchelor TT, Chiocca EA. Solitary sciatic nerve lymphoma as an initial manifestation of diffuse neurolymphomatosis. Case report and review of the literature. J Neurosurg. 2000;92(1):165-169.
17. Rahmani M, Birouk N, Amarti A, et al. T-cell lymphoma revealed by a mononeuritis multiplex: case report and review of literature. Rev Neurol (Paris). 2007;163(4):462-470.
18. Strobel K, Fischer K, Hany TF, Poryazova R, Jung HH. Sciatic nerve neurolymphomatosis - extent and therapy response assessment with PET/CT. Clin Nucl Med. 2007;32(8):646-648.
19. Ye BS, Sunwoo IN, Suh BC, Park JP, Shim DS, Kim SM. Diffuse large B-cell lymphoma presenting as piriformis syndrome. Muscle Nerve. 2010;41(3):419-422.
20. Tomita M, Koike H, Kawagashira Y, et al. Clinicopathological features of neuropathy associated with lymphoma. Brain. 2013;136(Pt 8):2563-2578.
21. Straathof CS, de Bruin HG, Dippel DW, Vecht CJ. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol. 1999;246(9):810-814.
22. Taylor BV, Kimmel DW, Krecke KN, Cascino TL. Magnetic resonance imaging in cancer related lumbosacral plexopathy. Mayo Clin Proc. 1997;72(9):823-829.
23. Hong CM, Lee SW, Lee HJ, et al. Neurolymphomatosis on F-18 FDG PET/CT and MRI Findings: A Case Report. Nucl Med Mol Imaging. 2011;45(1):76-78.
24. Boes M, Pels H, Klockgether T, Koch A, Schlegel U. High-grade B-cell NHL of the brachial plexus followed by infiltration of the spinal cord. J Neurol. 2008;255(1):135-137.
25. Abdulqadhr G, Molin D, Aström G, et al. Whole-body diffusionweighted imaging compared with FDG-PET/CT in staging of lymphoma patients. Acta Radiol. 2011;52(2):173-180.
26. Gu J, Chan T, Zhang J, Leung AY, Kwong YL, Khong PL. Whole-body diffusion weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR Am J Roentgenol. 2011;197(3):384-391.
27. Stéphane V, Samuel B, Vincent D, et al. Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas. Eur J Radiol. 2013;82(11):2011-2017.
28. Tanaka H, Yoshino K, Sakaida E, et al. Secondary neurolymphomatosis detected by whole body diffusion-weighted magnetic resonance imaging: a case report. J Clin Exp Hematop. 2013;53(3):221-226.
29. Bokstein F, Goor O, Shihman B, et al. Assessment of neurolymphomatosis by brachial plexus biopsy and PET/CT. Report of a case. J Neurooncol. 2005;72(2):163-167.
30. Grisariu S, Avni B, Batchelor TT. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood. 2010;115(24):5005-5011.
31. Kanter P, Zeidman A, Streifler J, et al. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis. Eur J Haematol. 2005;74(1):66-69.
32. Trojan A, Jermann M, Taverna C, Hany TF. Fusion PET-CT imaging of neurolymphomatosis. Ann Oncol. 2002;13(5):802-805.
33. Choi AL, Koh SH, Jun SY, et al. Lymphoma involving the ulnar nerve:sonographic findings. J Ultrasound Med. 2008;27(10):1527-1531.
34. Hanna R, Di Primio GA, Schweitzer M, Torres C, Sheikh A, Chakraborty S. Progressive neurolymphomatosis with cutaneous disease:response in a patient with mycosis fungoides. Skeletal Radiol. 2013;42(7):1011-1015.
35. Ahluwalia MS, Wallace PK, Peereboom DM. Flow cytometry as a diagnostic tool in lymphomatous or leukemic meningitis: ready for prime time? Cancer. 2012;118(7):1747-1753.
36. Hedge U, Filie A, Little RF, et al. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood. 2005;105(2):496-502.
37. Nückel H, Novotny JR, Noppeney R, Savidou I, Dührsen U. Detection of malignant haematopoietic cells in the cerebrospinal fluid by conventional cytology and flow cytometry. Clin Lab Haematol. 2006;28(1):22-29.
38. Viala K, Béhin A, Maisonobe T, et al. Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis? J Neurol Neurosurg Psychiatry. 2008; 79(7):778-782.
39. Baehring JM, Batchelor TT. Diagnosis and management of neurolymphomatosis. Cancer J. 2012;18(5):463-468.
40. Grimm S, Chamberlain MC. Peripheral Nerve Dysfunction Secondary to Lymphomatous Infiltration of the Nervous System by Non-Hodgkin's Lymphoma. EANO Magazine. 2014;4:65-70.
41. Grisold W, Briani C, Vass A. Malignant cell infiltration in the peripheral nervous system. Handb Clin Neurol. 2013;115:685-712.
42. Haaxma-Reiche H. Neurological complications of leukemia and lymphoma. Handb Clin Neurol. 2012;105:711-729.
43. Blioskas S, Tsaligopoulos M, Kyriafinis G. Bilateral secondary neurolymphomatosis of the internal auditory canal nerves: a case report. Am J Otolaryngol. 2013;34(5):556-558.
44. Roux S, Grossin M, De Bandt M, Palazzo E, Vachon F, Kahn MF. Angiotrophic large-cell lymphoma with mononeuritis multiplex mimicking systemic vasculitis. J Neurol Neurosurg Psychiatry. 1995;58(3):363-366.
45. Yamada S, Tanimoto A, Nabeshima A, et al. Diffuse large B-cell lymphoma presenting with neurolymphomatosis and intravascular lymphoma: a unique autopsy case with diverse neurological symptoms. Diagn Pathol. 2012;7:94.
46. Van den Bent MJ, de Bruin HG, Beun GD, Vecht CJ. Neurolymphomatosis of the median nerve. Neurology. 1995; 45(7):1403-1405.
47. Tsai HH, Chen YF, Hsieh ST, Chao CC. Neurolymphomatosis as the primary presentation of non-Hodgkin's Lymphoma. J Neurol Neurosurg Psychiatry. 2015;86(8):929-930.
48. Walk D, Handelsman A, Beckmann E, Kozloff M, Shapiro C. Mononeuropathy multiplex due to infiltration of lymphoma in hematologic remission. Muscle Nerve. 1998;21(6):823-826.
49. Levin N, Soffer D, Grissaru S, Aizikovich N, Gomori JM, Siegal T. Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis. J Neurooncol. 2008;90(1):77-83.
50. Levin KH, Lutz G. Angiotrophic large-cell lymphoma with peripheral nerve and skeletal muscle involvement: early diagnosis and treatment. Neurology. 1996;47(4):1009-1011.
51. Prayson RA. Angiotrophic large-cell lymphoma: simultaneous peripheral nerve and skeletal muscle involvement. Pathology. 1996;28(1):25-27.
52. Lynch KM, Katz JD, Weinberg DH, Lin DI, Folkerth RD. Isolated mononeuropathy multiplex--a rare manifestation of intravascular large B-cell lymphoma. J Clin Neuromuscul Dis. 2012;14(1):17-20.
53. Jiang QL, Pytel P, Rowin J. Disseminated intravascular large-cell lymphoma with initial presentation mimicking Guillain-Barré syndrome. Muscle Nerve. 2010;42(1):133-136.
54. Iwamoto FM, Abrey LE. Primary dural lymphomas: a review. Neurosurg Focus. 2006;21(5):E5.
55. Miranda RN, Glantz LK, Myint MA. Stage IE non-Hodgkin's lymphoma involving the dura: A clinicopathologic study of five cases. Arch Pathol Lab Med. 1996;120(3):254-260.
56. Dickenmann RC, Chason JL. Alterations in the dorsal root ganglia and adjacent nerves in the leukemias, the lymphomas and multiple myeloma. Am J Pathol. 1958;34(2):349-361.
57. Johnson PC. Hematogenous metastases of carcinoma to dorsal root ganglia. Acta Neuropathol. 1977;38(2):171-172.
58. Smith BE, Windebank AJ. Dorsal root ganglion disorders. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro B, eds. Neuromuscular disorders in clinical practice. 2nd ed. Boston, MA:Butterworth-Heinemann; 2002:478-500.
59. Estevez M, Chu C, Pless M. Small B-cell lymphoma presenting as diffuse dural thickening with cranial neuropathies. J Neurooncol. 2002;59(3):243-247.
60. Martin N, Masson C, Henin D, Mompoint D, Marsault C, Nahum H. Hypertrophic cranial pachymeningitis: assessment with CT and MR imaging. AJNR Am J Neuroradiol. 1989;10(3):477-484.
61. Grisold W, Cavaletti G, Windebank AJ. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol. 2012;14(suppl.):45-54.
62. Mato AR, Feldman T, Goy A. Proteasome inhibition and combination therapy for non-Hodgkin's lymphoma: from bench to bedside. Oncologist. 2012;17(5):694-707.
63. Ngo D, Patel S, Kim EJ, Brar R, Koontz MZ. Nelarabine neurotoxicity with concurrent intrathecal chemotherapy: Case report and review of literature. J Oncol Pharm Pract. 2015;21(4):296-300.
64. Briani C, Torre CD, Campagnolo M, et al. Lenalidomide in patients with chemotherapy-induced polyneuropathy and relapsed or refractory multple myeloma: results from a single-centre prospective study. J Peripher Nerv Syst. 2013;18(1):19-24.
65. Siddiqi T, Thomas SH, Chen R. Role of brentuximab in the treatment of relapsed or refractory Hodgkin lymphoma. Pharmgenomics Pers Med. 2014;7:79-85.
66. Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. Chemotherapyinduced peripheral neurotoxicity (CIPN): An update. Crit Rev Oncol Hematol. 2012;82(1):51-77.
67. Zinzani PL, Pellegrini C, Merla E, et al. Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study. Hematol Oncol. 2013;31(4):179-182.
68. Brioli A, Zannetti BA, Zamagni E. Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma. Haematologica. 2014;99(11):242-243.
69. Koh Y, Lee SY, Kim I, et al. Bortezomib-associated peripheral neuropathy requiring medical treatment is decreased by administering the medication by subcutaneous injection in Korean multiple myeloma patients. Cancer Chemother Pharmacol. 2014; 74(3):653-657.
70. Degen A, Alter M, Schenck F, Völker B, Kapp A, Gutzmer R. The handfoot- syndrome associatedwithmedical tumor therapy-classification and management. J Dtsch Dermatol Ges. 2010;8(9):652-661.
71. Chen M, Zhang L, Wand Q, Shen J. Pyridoxine for prevention of hand-foot syndrome caused by chemotherapy: a systematic review. PLoS One. 2013;8(8):e72245. Doi.
72. Dropcho EJ. Neurotoxicity of radiation therapy. Neurol Clin. 2010; 28(1):217-234.
73. Polomano RC, Farrar JT. Pain and neuropathy in cancer survivors:surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment. Am J Nurs. 2006; 106(3 Suppl):39-47.
74. Hughes RA, Britton T, Richards M. Effects of lymphoma on the peripheral nervous system. J R Soc Med. 1994;87(9):526-530.
75. Jaeckle KA. Neurologic manifestations of neoplastic and radiationinduced plexopathies. Semin Neurol. 2010;30(3):254-262.
76. De Vito EL, Quadrelli SA, Montiel GC, Roncoroni AJ. Bilateral diaphragmatic paralysis after mediastinal radiotherapy. Respiration. 1996;63(3):187-190.
77. Stubblefield MD. Radiation fibrosis syndrome: neuromuscular and musculoskeletal complications in cancer survivors. PM R. 2011; 3(11):1041-1054.
78. Delavan JA, Chino JP, Vinson EN. Gemcitabine-induced radiation recall myositis. Skeletal Radiol. 2015;44(3):451-455.
79. Grisold W, Vass A. Neuromuscular complications. Handb Clin Neurol 2012;105:781-803.
80. Nitsche M, Reible M, Pflüger KH, Bergmann M, Hermann RM. Malignant Triton Tumor of the Sciatic Nerve as a Secondary Malignancy after Extended Field Radiotherapy and Chemotherapy of Hodgkin's Disease. Case Rep Oncol. 2014;7(1):239-245.
81. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135-1140.
82. Gwathmey KG, Burns TM, Collins MP, Dyck PJ. Vasculitic neuropathies. Lancet Neurol. 2014;13(1):67-82.
83. Fain O, Hamidou M, Cacoub P, et al. Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum. 2007; 57(8):1473-1480.
84. Klein CJ, Moon JS, Mauermann ML, et al. The Neuropathies of Waldenström's acroglobulinemia (WM) and IgM-MGUS. Can J Neurol Sci. 2011;38(2):289-295.
85. Bayat E, Kelly JJ. Neurological complications in plasma cell dyscrasias. Handb Clin Neurol. 2012;105:731-746.
86. Ince PG, Shaw PJ, Fawcett PR, Bates D. Demyelinating neuropathy due to primary IgM kappa B cell lymphoma of peripheral nerve. Neurology. 1987;37(7):1231-1235.
87. Lin P, Hao S, Handy BC, Bueso-Ramos CE, Medeiros LJ. Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients. Am J Clin Pathol. 2005;123(2):200-205.
88. Noguhi M, Mori K, Yamazaki S, Suda K, Sato N, Oshimi K. Multifocal motor neuropathy caused by a B-cell lymphoma producing a monoclonal IgM autoantibody against peripheral nerve myelin glycolipids GM1 and GD1b. Br J Haematol. 2003;123(4):600-605.
89. Vallat JM, De Mascarel HA, Bordessoule D, et al. Non-Hodgkin malignant lymphomas and peripheral neuropathies--13 cases. Brain. 1995;118(Pt 5):1233-1245.
90. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol. 2002;55(1):4-13.
91. Lisak RP, Mitchell M, Zweiman B, Orrechio E, Asbury AK. Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol. 1977;1(1):72-78.
92. Briani C, Zambello R, Cavallaro T, et al. Improvement of peripheral nervous system manifestations of B-cell non-Hodgkin's lymphoma after rituximab therapy. J Peripher Nerv Syst. 2009;14(2):146-148.
93. Chahin N, Temesgen Z, Kurtin PJ, Spinner RJ, Dyck PJ. HIV lumbosacral radiculoplexus neuropathy mimicking lymphoma:diffuse infiltrative lymphocytosis syndrome (DILS) restricted to nerve? Muscle Nerve. 2010;41(2):276-282.
94. Gordon PH, Rowland LP, Younger DS, et al. Lymphoproliferative disorders and motor neuron disease: an update. Neurology. 1997; 48(6):1671-1678.
95. Louis ED, Hanley AE, Brannagan TH, et al. Motor neuron disease, lymphoproliferative disease, and bone marrow biopsy. Muscle Nerve. 1996;19(10):1334-1337.
96. Younger DS, Rowland LP, Latov N, et al. Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol. 1991;29(1):78-86.
97. Schold SC, Cho ES, Somasundaram M, Posner JB. Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol. 1979; 5(3):271-287.
98. Flanagan EP, Sandroni P, Pittock SJ, Inwards DJ, Jones LK Jr. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve. 2012;46(5):823-827.
99. Ladha SS, Dyck PJ, Spinner RJ, et al. Isolated amyloidosis presenting with lumbosacral radiculoplexopathy: description of two cases and pathogenic review. J Peripher Nerv Syst. 2006;11(4):346-352.
100. Laeng RH, Altermatt HJ, Scheithauer BW, Zimmermann DR. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production. Cancer. 1998;82(2):362-374.
101. Liu YC, Yang YH, Hsiao HH, et al. Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - a nationwide population-based matched-control study in Taiwan. BMC Cancer. 2012;12:503.
102. Goffinet DR, Glatstein EJ, Merigan TC. Herpes Zoster-Varicella Infections and Lymphoma. Ann Intern Med. 1972;76(2):235-240.
103. Coleman SL, Setty BN, Tan JN, Sakai O. Beyond B-Cell Lymphomas: A Case of Optic Nerve Anaplastic Large Cell Lymphoma in a HIV Positive Patient. Clin Neuroradiol. 2014;24(4):373-376.
104. Kim UR, Shah AD, Arora V, Solanki U. Isolated optic nerve infiltration in systemic lymphoma-a case report and review of literature. Ophthal Plast Reconstr Surg. 2010;26(4):291-293.
105. Matsuyama J, Ichikawa M, Oikawa T, et al. Primary CNS lymphoma arising in the region of optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage. Brain Tumor Pathol. 2014;31(3):222-228.
106. Tsutsumi K, Horiuchi T, Aoyama T, Hongo K. Isolated primary malignant lymphoma arising from the optic chiasm. J Clin Neurosci. 2013;20(12):1783-1786.
107. Vassal F, Pommier B, Boutet C, Forest F, Campolmi N, Nuti C. Isolated primary central nervous system lymphoma arising from the optic chiasm. Neurochirurgie. 2014;60(6):312-315.
108. Grimm S, Chamberlain M. Hodgkin's Lymphoma: A Review of Neurologic Complications. Adv Hematol. 2011;2011:624578.
109. Sakai N, Ito-Yamashita T, Takahashi G. Primary neurolymphomatosis of the lower cranial nerves presenting as Dysphagia and hoarseness:a case report. J Neurol Surg Rep. 2014;75(1):62-66.
110. Browning DJ, Fraser CM. Primary intraocular lymphoma mimicking multifocal choroiditis and panuveitis. Eye (Lond). 2007;21(6):880-881.
111. Davis JL. Intraocular lymphoma: a clinical perspective. Eye (Lond). 2013;27(2):153-162.
112. Faltas B, Phatak P, Sham R. Mental nerve neuropathy: frequently overlooked clinical sign of hematologic malignancies. Am J Med. 2011;124(1):1-2.
113. Laurencet FM, Anchisi S, Tullen E, Dietrich PY. Mental neuropathy:report of five cases and review of the literature. Crit Rev Oncol Hematol. 2000;34(1):71-79.
114. Broussalis E, Hutterer M, Oppermann K, et al. Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy. Acta Neurol Scand. 2012;126(3):11-16.
115. Liao B, Kamiya-Matsuoka C, Gong Y, Chen M, Wolf BA, Fowler NH. Primary natural killer/T-cell lymphoma presenting as leptomeningeal disease. J Neurol Sci. 2014;343(1-2):46-50.
116. Taylor JW, Flanagan EP, O'Neill BP, et al. Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report. Neurology. 2013;81(19):1690-1696.
117. Liu JK, Sayama C, Chin SS, Couldwell WT. Extranodal NK/T-cell lymphoma presenting as a pituitary mass. Case report and review of the literature. J Neurosurg. 2007;107(3):660-665.
118. Grau S, Schueller U, Weiss C, Tonn JC. Primary meningeal T-cell lymphoma at the clivus mimicking a meningioma. World Neurosurg. 2010;74(4-5):513-516.
119. Liang R, Todd D, Chan TK. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol. 1995;13(3):666-670.
120. Trese MT, Krohel GB, Hepler RS, Naeim F. Burkitt's lymphoma with cranial nerve involvement. Arch Ophthalmol. 1980;98(11):2015-2017.
121. Laine FJ, Braun IF, Jensen ME, Nadel L, Som PM. Perineural tumor extension through the foramen ovale: evaluation with MR imaging. Radiology. 1990;174(1):65-71.
122. Han MH, Chang KH, Kim IO, Kim DK, Han MC. Non-Hodgkin lymphoma of the central skull base: MR manifestations. J Comput Assist Tomogr. 1993;17(4):567-571.
123. Iplikcioglu AC, Dinc C, Bikmaz K, Ozcan D. Primary lymphoma of the trigeminal nerve. Br J Neurosurg. 2006;20(2):103-105.
124. Koyama T, O'uchi T, Matsue K. Neurolymphomatosis involving the trigeminal nerve and deep peroneal nerve in a patient with relapsed intravascular large B cell lymphoma. Eur J Haematol. 2010;85(3):275-276.
125. Rosen G. Cranial nerve involvement in malignant lymphoma. J Laryngol Otol. 1979;93(4):413-415.
126. Parker GD, Harnsberger HR. Clinical-radiologic issues in perineural tumor spread of malignant diseases of the extracranial head and neck. Radiographics. 1991;11(3):383-399.
127. Grisold W, Grisold A. Cancer around the brain. Neurooncol Pract. 2014;1:13-21.
128. Iwatsubo T, Nakano I, Tange T, Terauchi Y, Sonoo M. Monoradiculopathy multiplex-multiple infarction of the cauda equina caused by intravascular lymphomatosis. Rinsho Shinkeigaku. 1991; 31(11):1229-1234.
129. Kosa SC, Peller PJ, Klein CJ. T-cell neurolymphomatosis involving cauda equina and sciatic nerves. Neurology. 2009;72(1):98.
130. Dong Q,Wong KK, AvramAM. Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging. Clin Nucl Med. 2008;33(1):30-31.
131. Toner GC, Holmes R, Sinclair RA, Tang SK, Schwarz MA. Central nervous system lymphoma: primary lumbar nerve root infiltration. Acta Haematol. 1989;81(1):44-47.
132. Gs B1, J G, LA Mde S, et al. Bilateral vagus nerve neurolymphomatosis diagnosed using PET/CT and diffusion-weighted MRI. Clin Nucl Med. 2012;37(9):e225-e228.
133. Okada M, Takamatsu K, Oebisu N, Nakamura H. Solitary neurolymphomatosis of the brachial plexus mimicking benign nerve sheath tumour: case report. Br J Neurosurg. 2013;27(3):386-387.
134. Swarnkar A, Fukui MB, Fink DJ, Rao GR. MR imaging of brachial plexopathy in neurolymphomatosis. AJR Am J Roentgenol. 1997; 169(4):1189-1190.
135. Schlienger M, Ferroir JP, Huguet F, et al. Dropped Head Syndrome after whiplash injury in a patient treated for a Hodgkin's lymphoma by mantle field radiotherapy. Cancer Radiother. 2013; 17(1):44-49.
136. Buzelé R, Jacobi D, Maillot F, Magnant J, Couet C. Late onset malnutrition from esophageal and phrenic dysfunction after radiotherapy for Hodgkin's lymphoma: a case report. Nutrition. 2011;27(11-12):1206-1208.
137. Gilliland P, Holguin M. Phrenic nerve paralysis due to vincristine. Leuk Lymphoma. 2007;48(12):2452-2453.